Significance of 18 F-FDG PET and immunohistochemical GLUT-1 expression for cardiac myxoma
Open Access
- 16 June 2014
- journal article
- case report
- Published by Springer Nature in Diagnostic Pathology
- Vol. 9 (1) , 117
Abstract
Cardiac tumours are relatively rare and are difficult to diagnose merely with imaging techniques. We demonstrated an unusual case of left atrial myxoma, displaying the successful detection by positron emission tomography using 2-deoxy-2-[18 F] fluoro-D-glucose (18 F-FDG PET), correlated closely to more intense and enhanced immunoreactivity with glucose transporter-1 (GLUT-1) in a substantial number of cardiac myxoma cells. Further prospective studies are needed to validate the significance of 18 F-FDG PET findings for cardiac myxoma and the association with immunohistochemical GLUT-1 expression in its tumour cells, after collecting and investigating a larger number of surgical cases examined with both of them.Keywords
This publication has 9 references indexed in Scilit:
- Left Atrial Myxoma on FDG-PET/CTClinical Nuclear Medicine, 2013
- Benign cutaneous plexiform hybrid tumor of perineurioma and cellular neurothekeoma arising from the noseDiagnostic Pathology, 2013
- Sudden death as presenting symptom caused by cardiac primary multicentric left ventricle rhabdomyoma, in an 11-month-old baby. An immunohistochemical studyDiagnostic Pathology, 2012
- 18F-FDG PET Findings and GLUT-1 Expression in IPMNs of the PancreasJournal of Nuclear Medicine, 2008
- Detection of Cardiac Metastasis by Positron-Emission Tomography–Computed TomographyCirculation, 2005
- Significance of 18F‐fluorodeoxyglucose positron emission tomography (FDG‐PET) for detection of renal cell carcinoma and immunohistochemical glucose transporter 1 (GLUT‐1) expression in the cancerInternational Journal of Urology, 2002
- Detection of Cardiac Myxoma by F-18 FDG PETClinical Nuclear Medicine, 1999
- Facilitative glucose transportersEuropean Journal of Biochemistry, 1994
- On the Origin of Cancer CellsScience, 1956